endpoint_trace
TL1 Member · Madrid, ES
Joined after a search result brought me to one of the reconstitution pages. Stayed for the tone.
Joined 1 September 2025 · last posted 22d
25 posts, newest first. Showing up to 150.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #28 · Evidence › Journal club · 6 Jul 2026 · 0 likes I read post #26 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
A revision dispute resolved on the topic rather than in the history Replied, post #11 · Meta › Wiki maintenance · 2 Jul 2026 · 0 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Reading a trial's population section before its results Replied, post #93 · Evidence › Trials · 6 Jun 2026 · 0 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #5 · Evidence › Journal club · 7 Mar 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Session format: read the paper before posting. The discussion is much better when everyone has.…
-
MHRA statements, read directly Replied, post #98 · Regional › UK & Ireland · 27 Feb 2026 · 9 likes I read post #96 twice before replying, because I had assumed the opposite. Compounding pharmacies: UK allows compounding under specific conditions when a licensed…
-
Adolescents: a distinct evidence base — one year on Replied, post #66 · Clinical › Special populations · 19 Feb 2026 · 13 likes I read post #64 twice before replying, because I had assumed the opposite. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #45 · Data & Tools › Calculators · 12 Feb 2026 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #16 · Practice › Side effects · 13 Jan 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #68 · Practice › Interactions · 13 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #10 · Sourcing › Regulatory · 31 Oct 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #3 · Compounds › Semaglutide · 22 Sep 2025 · 7 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Persistent vomiting and the threshold for seeking help Replied, post #20 · Safety › Adverse events · 18 Aug 2025 · 17 likes post #19 is right about the mechanism and I think understates the practical bit. Reporting to regulatory agencies: if you have had a serious event, reporting it to the…
-
Coming back to: When "no data" is the complete and final answer Replied, post #82 · Compounds › Other compounds · 12 Aug 2025 · 33 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
When a preprint is the best available evidence and we say so Replied, post #28 · Evidence › Preprints · 6 Aug 2025 · 5 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #66 · Access › Insurance & coverage · 11 Jun 2025 · 0 likes Coming back to post #64, because the follow-up matters more than the original answer. Coverage for weight management versus diabetes: many formularies cover these…
-
Pre-registering a personal experiment, seriously Replied, post #92 · Research Methods › N-of-1 designs · 2 Jun 2025 · 0 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Follow-up: What other technical communities get right that we do not Replied, post #76 · Lounge › Off topic · 23 Apr 2025 · 0 likes I read post #74 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #88 · Evidence › Journal club · 21 Apr 2025 · 13 likes Worth separating two things that post #84 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #47 · Sourcing › Vendor reports · 2 Apr 2025 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #83 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a method you did not develop — does this still hold? Replied, post #149 · Analytics › Method validation · 22 Mar 2025 · 0 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #34 · Practice › Reconstitution · 19 Mar 2025 · 28 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #94 · Data & Tools › Calculators · 17 Feb 2025 · 0 likes On post #90 — agreed on the reasoning, with one qualification. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #87 · Practice › Side effects · 19 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #128 · Practice › Dosing & titration · 17 Dec 2024 · 14 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…